| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| L-Carnosine | Age-Related Cognitive Decline | 2 | PM | 33806459 | 📋 | The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-Analysis |
| L-Carnosine | Age-Related Cognitive Decline | 1 | PM | 33768569 | 📋 | Carnosine improves aging-induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ) |
| L-Carnosine | Alzheimer's Disease | 1 | PM | 35091983 | 📋 | Swimming exercise versus L-carnosine supplementation for Alzheimer's dementia in rats: implication of circulating and hippocampal FNDC5/irisin |
| L-Carnosine | Autism Spectrum Disorder | 1 | PM | 35215455 | 📋 | Oral Supplementation with L-Carnosine Attenuates Social Recognition Deficits in CD157KO Mice via Oxytocin Release |
| L-Carnosine | Cognitive Disorders | 1 | PM | 35091983 | 📋 | Swimming exercise versus L-carnosine supplementation for Alzheimer's dementia in rats: implication of circulating and hippocampal FNDC5/irisin |
| L-Carnosine | Dementia | 1 | PM | 32134423 | 📋 | Carnosine ameliorates age-related dementia via improving mitochondrial dysfunction in SAMP8 mice |
| L-Carnosine | Diabetic Encephalopathy | 1 | PM | 35302398 | 📋 | Carnosine improves cognitive impairment through promoting SIRT6 expression and inhibiting ER stress in a diabetic encephalopathy model |
| L-Carnosine | Mild Cognitive Impairment | 1 | PM | 33806459 | 📋 | The Therapeutic Potential of Carnosine/Anserine Supplementation against Cognitive Decline: A Systematic Review with Meta-Analysis |
| L-Carnosine | Schizophrenia | 1 | PM | 36946070 | 📋 | Cognitive and negative symptoms in schizophrenia with L-Carnosine adjuvant therapy - A randomized double-blind placebo-controlled study |
